Vous êtes ici

NetraMark Holdings Inc.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
AIAI
Indice CSE: 
Devise: 

NetraMark Holdings is an AI healthtech company focused on addressing both acute and non-acute brain-centric conditions. We have developed an ecosystem of innovative products that directly support brain-related conditions. Our world-renowned team and partners are disrupting traditional mental wellness treatments and are positioned at the forefront of critical research and innovations. NetraMark, a wholly owned subsidiary of NetraMark Holdings Inc., is providing proprietary next-generation AI solutions for pharmaceutical and biotechnology companies across the spectrum of disease. The company is based in Toronto, Ontario. For more information, visit https://www.netramark.com/.

Vous êtes ici

NetraMark Holdings Inc. (AIAI)

SEDAR Information

Information d'entreprise

Addresse
101-1655 Dupont Street
Toronto, ON M6P 3T1
Canada
Téléphone
403-681-2549
Courriel
swapan@nurosene.com
URL
https://www.netramark.com/
Date d’inscription à la cote
Lundi, juin 7, 2021
Agent de transfert
Odyssey Trust Company

Capitalisation

Capitalisation: 
67153644
Réservé à l'émission: 
16143965

Company Officers

George Achilleos, Chief Executive Officer
Swapan Kakumanu, Chief Financial Officer

Bulletins

30/01/2023

2023-0142 - Changement de Nom et de Symbole - Nurosene Health Inc. (MEND)

le 30 janvier/January 2023

Nurosene Health Inc. (MEND) has announced a name and symbol change to NetraMark Holdings Inc. (AIAI).